Next, an in-depth exploration of the regulatory network of NPs targeting Nrf2 to protect the heart will help delay the development of cardiovascular disease and improve its prognosis, which may be a promising therapeutic strategy. This evidence concerns the gene NFE2L2 and cardiovascular disorder.